Cargando…

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas

Immunotherapy in soft tissue sarcoma (STS) has experienced a surge of interest in the past decade, contributing to an expanding number of therapeutic options for this extremely heterogenous group of rare malignancies. Immune checkpoint inhibitors (CPIs) targeting the PD-1 and CTLA-4 axes have demons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerrison, William G. J., Lee, Alexander T. J., Thway, Khin, Jones, Robin L., Huang, Paul H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945421/ https://www.ncbi.nlm.nih.gov/pubmed/35327375 http://dx.doi.org/10.3390/biomedicines10030573

Ejemplares similares

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Merry, Eve, et al.
Publicado: (2021)

The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling
por: Pankova, Valeriya, et al.
Publicado: (2021)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
por: Noujaim, Jonathan, et al.
Publicado: (2016)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018)

Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
por: Thway, Khin, et al.
Publicado: (2016)

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
por: Gordon, Erlinda M., et al.
Publicado: (2016)

Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
por: Milighetti, Martina, et al.
Publicado: (2021)

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma
por: Thway, Khin, et al.
Publicado: (2015)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)

Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma
por: Kerrison, William G. J., et al.
Publicado: (2022)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Proteomic research in sarcomas – current status and future opportunities
por: Burns, Jessica, et al.
Publicado: (2020)

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
por: Sousa, Luana Madalena, et al.
Publicado: (2021)

Soft Tissue Myoepithelial Carcinoma Metastatic to the Cecum: Highlighting an Unusual Metastatic Pattern and the Need for Diagnostic Awareness
por: Mourtzoukou, Despoina, et al.
Publicado: (2016)

Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre
por: Thway, Khin, et al.
Publicado: (2009)

The evolving management of epithelioid sarcoma
por: Alves, Anneke, et al.
Publicado: (2021)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives
por: Vibert, Julien, et al.
Publicado: (2022)

Phase III Soft Tissue Sarcoma Trials: Success or Failure?
por: Lee, Alexander T. J., et al.
Publicado: (2017)

Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022)

Radiation Therapy in Adult Soft Tissue Sarcoma—Current Knowledge and Future Directions: A Review and Expert Opinion
por: Roeder, Falk
Publicado: (2020)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

The Future of Radiation Oncology in Soft Tissue Sarcoma
por: Naghavi, Arash O., et al.
Publicado: (2018)

Sarcoma Immunotherapy: Past Approaches and Future Directions
por: D'Angelo, S. P., et al.
Publicado: (2014)

Diagnostic Differences in Expert Second-Opinion Consultation Cases at a Tertiary Sarcoma Center
por: Rupani, Asha, et al.
Publicado: (2020)

Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck
por: Flucke, Uta, et al.
Publicado: (2020)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)

Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions
por: Montella, Liliana, et al.
Publicado: (2021)

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
por: Raj, Shailaja, et al.
Publicado: (2018)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
por: Panagi, Myrofora, et al.
Publicado: (2022)

Supervised Machine-Learning Enables Segmentation and Evaluation of Heterogeneous Post-treatment Changes in Multi-Parametric MRI of Soft-Tissue Sarcoma
por: Blackledge, Matthew D., et al.
Publicado: (2019)

The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities
por: Noujaim, Jonathan, et al.
Publicado: (2017)

The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
por: Pomella, Silvia, et al.
Publicado: (2020)

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
por: D'Angelo, S. P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ac8t8398anl26t9i7iq2h488a9